What is the appropriate management for a 64-year-old male presenting to the emergency department with chest pain, tightness, and tachypnea, whose coronary angiography shows a mid left anterior descending artery (LAD) 60% stenosis, distal left circumflex artery (LCx) 70% stenosis, and mid right coronary artery (RCA) 80% stenosis, and who smokes a pack of cigars per day?

Immediate Coronary Revascularization with PCI and Aggressive Medical Therapy

This 64-year-old male with acute chest pain, tachypnea, and multi-vessel coronary disease (mid LAD 60%, distal LCx 70%, mid RCA 80% stenosis) requires urgent coronary angiography with revascularization—most likely PCI of the culprit lesion(s)—combined with dual antiplatelet therapy, statin, beta-blocker, ACE inhibitor, and mandatory smoking cessation.

Risk Stratification and Timing

This patient presents with high-risk features that mandate urgent intervention 1:

• Active chest pain with tachypnea (suggesting ongoing ischemia)
• Multi-vessel disease with significant stenoses (≥70% in LCx and 80% in RCA)
• Heavy tobacco use (pack of cigars daily—a major risk factor)

Coronary angiography should be performed within 24 hours of presentation, as he falls into the high-risk category requiring early invasive strategy 1, 2. If he develops hemodynamic instability, recurrent chest pain despite medical therapy, or significant arrhythmias, angiography should be performed immediately (within 2 hours) 1.

Immediate Medical Management (Pre-Revascularization)

Antiplatelet Therapy

• Aspirin 162-325 mg chewed immediately (unless contraindicated) 3
• Ticagrelor 180 mg loading dose (preferred over clopidogrel in ACS) 1, 2
  • Alternative: Prasugrel 60 mg if no prior stroke/TIA and age <75 years
  • Clopidogrel 600 mg only if ticagrelor/prasugrel contraindicated

Anticoagulation

• Enoxaparin 1 mg/kg subcutaneously twice daily OR unfractionated heparin 1
• Continue until revascularization completed

Anti-Ischemic Therapy

• IV nitroglycerin if chest pain persists (avoid if hypotensive)
• Beta-blocker (metoprolol or carvedilol) unless contraindicated
• High-intensity statin (atorvastatin 80 mg or rosuvastatin 40 mg) immediately 1, 2

Revascularization Strategy

Given the angiographic findings showing multi-vessel disease, the decision between PCI and CABG requires Heart Team discussion 1, 4. However, key considerations:

Favor PCI if:

• Single culprit lesion identified (most likely the RCA at 80% or LCx at 70%)
• Patient hemodynamically stable after initial medical therapy
• Anatomy suitable for PCI

Consider CABG if:

• Left main equivalent disease (proximal LAD + LCx involvement)
• Complex three-vessel disease with high SYNTAX score
• Diabetes present (though not mentioned in this case)

Most likely approach: PCI of the culprit lesion (highest grade stenosis causing acute symptoms—likely the RCA 80%) with staged PCI of other lesions if ischemia-driven, or medical management if asymptomatic 4.

Stent Selection

• Drug-eluting stent (DES) is preferred over bare metal stent 5
• Newer-generation DES reduces restenosis and thrombosis risk

Post-Revascularization Medical Therapy (Discharge Medications)

Dual Antiplatelet Therapy (DAPT)

• Aspirin 75-100 mg daily indefinitely 1, 6
• Ticagrelor 90 mg twice daily for 12 months minimum 1, 5
  • Do NOT switch to clopidogrel unless bleeding complications occur
  • After 12 months, continue aspirin alone

Cardiovascular Risk Reduction

• High-intensity statin (atorvastatin 80 mg daily) targeting LDL <70 mg/dL 4
• Beta-blocker (metoprolol succinate 50-200 mg daily or carvedilol 6.25-25 mg twice daily)
• ACE inhibitor (lisinopril 10-40 mg daily) or ARB if ACE-intolerant 4
• Consider eplerenone if LVEF <35% develops

Critical: Smoking Cessation

Absolute requirement: Complete cessation of cigar smoking 7

• Refer to smoking cessation program
• Consider pharmacotherapy (varenicline or bupropion)
• Nicotine replacement therapy
• This is NON-NEGOTIABLE for prognosis

Common Pitfalls to Avoid

1. Do NOT use clopidogrel instead of ticagrelor/prasugrel in ACS unless contraindications exist—this increases stent thrombosis risk 5

2. Do NOT delay angiography beyond 24 hours in this high-risk patient—he has multi-vessel disease with ongoing symptoms 1

3. Do NOT stop DAPT prematurely—minimum 12 months required after DES placement in ACS setting 1, 6

4. Do NOT perform complete revascularization of all lesions during index procedure unless patient unstable—staged approach for non-culprit lesions is safer 4

5. Do NOT discharge without intensive smoking cessation counseling—continued smoking dramatically increases recurrent events 7

Monitoring and Follow-Up

• Cardiac biomarkers (troponin) at 6-12 hours to confirm NSTEMI vs unstable angina 1
• Echocardiogram to assess LV function post-procedure 2
• Lipid panel within 24 hours of admission 2
• Renal function monitoring (creatinine) given contrast exposure
• Outpatient cardiology follow-up within 2 weeks
• Cardiac rehabilitation referral mandatory 4

The combination of urgent revascularization, potent antiplatelet therapy, and aggressive risk factor modification—particularly smoking cessation—offers this patient the best chance for survival and quality of life improvement.